Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Relative Value
The Relative Value of one Shanghai Rendu Biotechnology Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 51.28 CNY, Shanghai Rendu Biotechnology Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Shanghai Rendu Biotechnology Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
|
2.1B CNY | 11.8 | -199.2 | -59.2 | -59.2 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.4 | 44.2 | 27.6 | 33 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.4B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.2B CHF | 3.9 | 37.5 | 15.5 | 30.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
118.2B DKK | 4.2 | 32.5 | 15 | 17.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.3B USD | 2.8 | 29.8 | 13.5 | 17.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.5B GBP | 2.7 | 28.8 | 12.8 | 20.9 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.6B CNY | 9.4 | 25.8 | 23.3 | 23.3 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | 1.2 | -18.8 | 19 | 89.9 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.2B CHF | 5.3 | 21.5 | 14 | 19 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.1T KRW | 88.1 | -32.3 | -74.9 | -70.9 |